903630-24-0 Usage
Uses
Used in Pharmaceutical Industry:
(2-Methylbenzo[d]oxazol-5-yl)MethanaMine is utilized as a building block in the development of pharmaceutical compounds due to its unique structure and potential biological activities. Its presence in drug molecules can contribute to desired pharmacological properties, making it a valuable component in medicinal chemistry.
Used in Organic Synthesis:
In the field of organic synthesis, (2-Methylbenzo[d]oxazol-5-yl)MethanaMine serves as a versatile intermediate for the synthesis of various organic compounds. Its reactivity and structural features allow it to participate in multiple chemical reactions, facilitating the creation of a wide range of products.
Used in Medicinal Chemistry Research:
(2-Methylbenzo[d]oxazol-5-yl)MethanaMine is employed as a subject of study in medicinal chemistry research to explore its potential biological activities. Understanding how (2-Methylbenzo[d]oxazol-5-yl)MethanaMine interacts with biological systems can lead to the discovery of new therapeutic agents or contribute to the optimization of existing drugs.
Used in Drug Discovery:
As part of the drug discovery process, (2-Methylbenzo[d]oxazol-5-yl)MethanaMine is investigated for its potential to treat or manage various diseases and conditions. Its unique structure may offer insights into the development of novel pharmaceuticals with improved efficacy and safety profiles.
Check Digit Verification of cas no
The CAS Registry Mumber 903630-24-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,0,3,6,3 and 0 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 903630-24:
(8*9)+(7*0)+(6*3)+(5*6)+(4*3)+(3*0)+(2*2)+(1*4)=140
140 % 10 = 0
So 903630-24-0 is a valid CAS Registry Number.
903630-24-0Relevant academic research and scientific papers
ANTI-INFECTIVE COMPOUNDS
-
Page/Page column 71-72, (2016/06/28)
The present invention relates to small molecule compounds having the general formula (I): wherein A is a moiety selected from the group consisting of formulae (A) to (K) and their use in the treatment of bacterial infections, in particular Tuberculosis.
